UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibiotic resistance : epidemiology and therapeutics

Diagnostic microbiology and infectious disease, 1992-02, Vol.15 (2), p.53S-60S

1992

Volltextzugriff (PDF)

Association of nutritional status with the response to infection with Leishmania chagasi

The American journal of tropical medicine and hygiene, 2008-10, Vol.79 (4), p.591-598

2008

Volltextzugriff (PDF)

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries

The international journal of tuberculosis and lung disease, 2014-11, Vol.18 (11), p.1327-1336

2014

Volltextzugriff (PDF)

Fever in hospitalized patients: With special reference to the medical service

The American journal of medicine, 1987-03, Vol.82 (3), p.580-586

1987

Volltextzugriff (PDF)

Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Clinical infectious diseases, 1998-06, Vol.26 (6), p.1482-1483

1998

Volltextzugriff (PDF)

Health outcomes among HIV‐positive Latinos initiating antiretroviral therapy in North America versus Central and South America

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20684-n/a

2016

Volltextzugriff (PDF)

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

Clinical infectious diseases, 2007-01, Vol.44 (2), p.159-177

2007

Volltextzugriff (PDF)

A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA‐ACCORD and CCASAnet clinical cohorts

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20707-n/a

2016

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

Journal of antimicrobial chemotherapy, 2016-11, Vol.71 (11), p.3168-3178

2016

Volltextzugriff (PDF)

Report from the Antimicrobial Agents Committee

The Journal of infectious diseases, 1987-11, Vol.156 (5), p.700-705

1987

Volltextzugriff (PDF)

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate

AIDS research and human retroviruses, 2012-11, Vol.28 (11), p.1412-1421

2012

Volltextzugriff (PDF)

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

Infection control and hospital epidemiology, 1997-04, Vol.18 (4), p.275-291

1997

Volltextzugriff (PDF)

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Clinical infectious diseases, 1997-09, Vol.25 (3), p.584-599

1997

Volltextzugriff (PDF)

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

The Journal of infectious diseases, 2024-04, Vol.229 (4), p.1131-1140

2024

Volltextzugriff (PDF)

Therapeutic and epidemiologic recommendations to reduce the spread of type-I β-lactamase resistance

Diagnostic microbiology and infectious disease, 1992-02, Vol.15 (2), p.49S-52S

1992

Volltextzugriff (PDF)

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

BMC infectious diseases, 2022-04, Vol.22 (1), p.341-341, Article 341

2022

Volltextzugriff (PDF)

Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America

PLoS medicine, 2011-10, Vol.8 (10), p.e1001111-e1001111

2011

Volltextzugriff (PDF)

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: An Overview

Clinical infectious diseases, 1995-08, Vol.21 (Supplement-1), p.S12-S31

1995

Volltextzugriff (PDF)

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Disease-Specific Recommendations

Clinical infectious diseases, 1995-08, Vol.21 (Supplement-1), p.S32-S43

USPHS/IDSA Prevention of Opportunistic Infections Working Group

1995

Volltextzugriff (PDF)

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Introduction

Clinical infectious diseases, 1995-08, Vol.21 (Supplement-1), p.S1-S11

1995

Volltextzugriff (PDF)

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

AIDS research and human retroviruses, 2020-01, Vol.36 (1), p.48-57

2020

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibiotic resistance : epidemiology and therapeutics

Association of nutritional status with the response to infection with Leishmania chagasi

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries

Fever in hospitalized patients: With special reference to the medical service

Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Health outcomes among HIV‐positive Latinos initiating antiretroviral therapy in North America versus Central and South America

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA‐ACCORD and CCASAnet clinical cohorts

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

Report from the Antimicrobial Agents Committee

RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

Therapeutic and epidemiologic recommendations to reduce the spread of type-I β-lactamase resistance

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: An Overview

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Disease-Specific Recommendations

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Introduction

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

Aktive Filter

Suchergebnisse filtern